Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
$661M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$484M |
| 3 |
Amazon
AMZN
|
$482M |
| 4 |
Netflix
NFLX
|
$345M |
| 5 |
Pfizer
PFE
|
$314M |
Top Sells
| 1 |
Apple
AAPL
|
$900M |
| 2 |
Microsoft
MSFT
|
$393M |
| 3 |
UnitedHealth
UNH
|
$388M |
| 4 |
Merck
MRK
|
$272M |
| 5 |
Bank of America
BAC
|
$265M |
Sector Composition
| 1 | Technology | 22.26% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 12.79% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Acacia Research
ACTG
$318M
| $451K | ﹤0.01% |
202,774
-152
| -0.1% | -$338 |
|
2802
eGain
EGAN
$178M
| $449K | ﹤0.01% |
61,272
-8,947
| -13% | -$65.6K |
|
|
CHK
2803
DELISTED
Chesapeake Energy Corporation
CHK
| $447K | ﹤0.01% |
12,907
+113
| +0.9% | +$3.91K |
|
2804
HBT Financial
HBT
$828M
| $446K | ﹤0.01% |
42,391
+27,852
| +192% | +$293K |
|
2805
Clear Channel Outdoor Holdings
CCO
$656M
| $442K | ﹤0.01% |
690,408
-355,850
| -34% | -$228K |
|
2806
Clearfield
CLFD
$455M
| $441K | ﹤0.01% |
37,263
-340
| -0.9% | -$4.02K |
|
2807
X4 Pharmaceuticals
XFOR
$78.6M
| $439K | ﹤0.01% |
1,462
+389
| +36% | +$117K |
|
2808
FS Bancorp
FSBW
$321M
| $437K | ﹤0.01% |
24,286
+11,970
| +97% | +$215K |
|
2809
BlackRock MuniVest Fund
MVF
$376M
| $435K | ﹤0.01% |
53,753
| – | – |
|
|
MMP
2810
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $434K | ﹤0.01% |
11,883
-527,681
| -98% | -$19.3M |
|
|
NBEV
2811
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $434K | ﹤0.01% |
312,140
+142
| +0% | +$197 |
|
2812
KalVista Pharmaceuticals
KALV
$796M
| $433K | ﹤0.01% |
56,672
+17,193
| +44% | +$131K |
|
|
SRGA
2813
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $433K | ﹤0.01% |
8,436
-690
| -8% | -$35.4K |
|
|
STXB
2814
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $432K | ﹤0.01% |
41,719
+4,304
| +12% | +$44.6K |
|
|
WMC
2815
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $430K | ﹤0.01% |
18,773
-34,849
| -65% | -$798K |
|
2816
Fulcrum Therapeutics
FULC
$414M
| $428K | ﹤0.01% |
+35,830
| New | +$428K |
|
2817
International Money Express
IMXI
$430M
| $427K | ﹤0.01% |
46,771
+4,864
| +12% | +$44.4K |
|
2818
Ohio Valley Banc Corp
OVBC
$172M
| $427K | ﹤0.01% |
14,260
+6,679
| +88% | +$200K |
|
|
ENZ
2819
DELISTED
Enzo Biochem, Inc.
ENZ
| $426K | ﹤0.01% |
168,487
-49,922
| -23% | -$126K |
|
2820
Dianthus Therapeutics
DNTH
$853M
| $425K | ﹤0.01% |
4,226
+1,004
| +31% | +$101K |
|
2821
BlackRock MuniYield Quality Fund II
MQT
$216M
| $424K | ﹤0.01% |
34,321
| – | – |
|
|
AKRX
2822
DELISTED
Akorn, Inc.
AKRX
| $423K | ﹤0.01% |
753,290
+45,130
| +6% | +$25.3K |
|
2823
Global Water Resources
GWRS
$269M
| $422K | ﹤0.01% |
41,450
-75
| -0.2% | -$764 |
|
2824
Investar Holding Corp
ISTR
$227M
| $419K | ﹤0.01% |
32,823
-12
| -0% | -$153 |
|
2825
Riverview Bancorp
RVSB
$106M
| $419K | ﹤0.01% |
83,562
+6,998
| +9% | +$35.1K |
|